Hair loss can be difficult to judge when you are looking at your own hair every day. A wider parting, a changing hairline or more hair in the shower may leave you wondering whether what you are seeing is normal. The NHS says that losing around 50 to 100 hairs a day can be part of the usual hair cycle. Persistent thinning or a noticeable change deserves a closer look. [1]
This guide brings together research on how common hair loss is, the conditions behind it and the treatments available. UK findings are identified where they exist. Studies from elsewhere are included with their dates and populations, so a figure about one group of patients is not mistaken for a fact about everyone in Britain.
Hair loss figures worth knowing
- Normal daily shedding is often put at 50 to 100 hairs by the NHS. That range is a guide, not a test for diagnosing hair loss. [1]
- In a 1998 community study of men aged 18–49, 42% had moderate to extensive male pattern hair loss. This was a US study, not a UK population count. [4]
- A British study published in 2001 found female pattern hair loss in 6% of women under 50 and 38% of those aged 70 or over. The women were attending a dermatology clinic for other concerns. [3]
- UK primary-care research reported an adult alopecia areata prevalence of 0.58% in 2018: roughly six people in every thousand. [5]
- A European survey of 729 men who reported hair loss found that 62% thought it could affect self-esteem. The survey included the UK. [12]
- In the ISHRS 2025 census, members reported using FUE for 85.4% of male and 68.2% of female hair restoration operations performed in 2024. These figures describe participating practices, not the general population. [19]
How common is hair loss in the UK?
There is no single figure in the studies below that counts every UK resident with every form of hair loss. Some research measures a diagnosed condition, some records people seeking treatment and some asks people whether they think their hair is thinning. Those are different questions, so their answers should not be added together.
The distinction matters when comparing headlines. A GP-record study will miss people who never seek medical advice. A specialist clinic will see more severe or troublesome cases than a typical high street. A survey of older adults will usually find more pattern hair loss than a survey of people in their twenties. The population behind a statistic is as important as the percentage itself.
It is also worth separating the number affected today from the chance of developing a condition over a lifetime. A lifetime estimate includes people who may develop it in the future or who have already recovered. A figure for a single year counts a different group. Two apparently conflicting percentages may therefore both be accurate, provided they have been labelled properly. Where a headline leaves out that distinction, the original study is worth checking.
Why pattern hair loss accounts for so much of the discussion
Male and female pattern hair loss are common, long-term causes of thinning. They are often discussed together under the name androgenetic alopecia, although the appearance and assessment differ. In men, inherited susceptibility and the hormone dihydrotestosterone, or DHT, contribute to changes in the follicles. Hair gradually becomes finer, reducing the coverage it provides. [2]
In women, thinning often develops across the top of the scalp while the front hairline remains relatively unchanged. Genetics can come from either side of the family. Female pattern loss can also occur alongside a hormonal condition such as polycystic ovary syndrome, but the appearance of thinning alone does not establish that diagnosis. [6]
What the research says about men
The 1998 community study gives a useful example of how age affects the figures. Researchers assessed men aged 18–49 using a standard hair-loss classification. Moderate to extensive loss, defined as type III or above, affected 16% of those aged 18–29 and 53% of those aged 40–49. Across the group, the figure was 42%. [4]
This does not mean that every man follows the same course, or that 42% of all British men have that degree of loss today. It describes a particular sample and threshold. A small change at the temples would not necessarily fall into the category used by the researchers. When comparing studies, check whether they include mild recession or count only more established loss.
What the research says about women
In the British study by Birch and colleagues, researchers examined 377 women aged 18–99 who had attended a general dermatology clinic for reasons unrelated to hair growth. Female pattern hair loss was diagnosed in 6% of women under 50, rising to 38% in women aged 70 and above. [3]
These findings support an increase with age, but they are not a current census of women in the UK. They also measured a specific pattern of thinning, rather than every episode of shedding a woman might experience. Someone who temporarily sheds hair after an illness and someone with gradual thinning over several years should not automatically be counted as having the same condition.
Does hair loss start at a particular age?
There is no birthday at which hair loss becomes inevitable. Male pattern loss may begin after puberty and progress over years or decades. Female pattern loss commonly becomes apparent later, often in the fifties or sixties, although younger women can be affected. Family history can offer clues, but it cannot provide a timetable. [2] [6]
For someone noticing a change, a useful starting point is the history: when it began, whether it has been gradual or sudden, and whether the scalp looks or feels different. Comparing photographs taken in similar light can make that conversation more specific. A photograph shows the change you are concerned about; it does not, by itself, establish the cause.
Alopecia areata: the UK evidence
Alopecia areata is a different condition from pattern hair loss. UK primary-care research reported a recorded adult prevalence of 0.58% in 2018. The study also calculated an incidence rate of 0.26 per 1,000 person-years, which describes new recorded cases over time. Prevalence and incidence measure different things and should not be used interchangeably. [5]
Put simply, prevalence asks how many people have a condition at a particular point, while incidence asks how often new cases occur. Neither tells an individual how much hair they will lose or how quickly it will return. Medical records also depend on people seeking care and a diagnosis being recorded, so they are not a perfect count of every affected person.
How alopecia areata differs from gradual thinning
With alopecia areata, the immune system attacks the hair follicles and interrupts hair growth. It often produces one or more smooth bald patches, although the pattern can be more widespread. The scalp is not necessarily sore or visibly inflamed. Some people also notice changes in their nails. [7]
Hair can grow back, but the course is unpredictable. Regrowth may be followed by another episode, and a small patch does not reveal what will happen over the following year. This is why advice should be based on the diagnosis, extent and history of the condition, rather than a general promise that all patchy hair loss is temporary. [7]
Alopecia totalis and alopecia universalis
The name alopecia totalis is used when all scalp hair is lost. Alopecia universalis describes loss affecting the scalp, face and body. These are extensive forms of alopecia areata, rather than later stages of ordinary male pattern baldness. Their treatment needs are different from those of someone with a receding hairline. [8]
A specialist assessment can establish what is happening and discuss the available options. Complete spontaneous regrowth is less likely with extensive disease than with a few small patches. Hair replacement, practical support and help with the emotional effects can be discussed alongside medical treatment. A hair transplant should not be assumed to solve an active immune-related hair-loss condition. [7] [18]
Health, habits and temporary shedding
Hair loss is often blamed on stress, diet or a particular product before the cause has been established. Sometimes a recent illness, substantial weight loss or a change in medication is relevant. In other cases, gradual hereditary thinning has become more noticeable at the same time. Several things can happen together, which makes a careful history more useful than guessing from one symptom. [1] [9]
It helps to take a list of medicines and supplements to an appointment and mention recent health changes. That gives the clinician something concrete to work with. It also avoids spending months changing shampoos or buying supplements while the underlying problem remains unclear.
Stress and the hair cycle
Telogen effluvium is increased shedding caused by a disruption to the normal hair cycle. It can follow significant physical or emotional stress, and the shedding may begin around three months after the trigger. The delay explains why an illness or difficult period can seem unrelated by the time more hair appears on the brush. [9]
The British Association of Dermatologists describes a shedding phase that commonly lasts three to six months, with longer needed for normal volume to return. Persistent or repeated shedding needs reassessment, especially if a trigger has not been identified. Telling somebody simply to relax does not establish the diagnosis or address another possible cause. [9]
Can antidepressants contribute to hair loss?
Hair loss has been reported with some antidepressants, but it should not be described as an expected effect of every medicine in that group. A large retrospective study published in 2018 compared recorded hair-loss diagnoses among people taking different antidepressants. It found differences between medicines, including a higher relative risk with bupropion than with several alternatives. [10]
The study used healthcare records and cannot prove that a particular tablet caused an individual’s shedding. If hair loss begins after starting or changing a prescription, discuss the timing with the prescriber. Other explanations may need checking. Do not stop an antidepressant abruptly or switch it yourself because of a hair-loss concern; the benefits, side effects and withdrawal risks need to be considered together.
Diet, deficiencies and hair supplements
Iron deficiency and marked weight loss are among the possible contributors to shedding. Whether tests are useful depends on the history and examination. A supplement is most useful when it addresses an identified need; the words “hair growth” on a label do not show that it will treat the cause of thinning. [1] [9]
Biotin is a good example. The US National Institutes of Health notes that evidence for hair benefits from biotin supplements is limited, particularly in otherwise healthy people. High intakes can also interfere with certain blood tests, including some thyroid tests. Tell the clinician what you are taking, even if it was bought as a beauty supplement rather than prescribed. [11]
What do studies show about smoking?
A study published in 2021 compared 500 smokers with 500 non-smokers, all men aged 20–35. Researchers found some degree of androgenetic alopecia in 425 smokers and 200 non-smokers: 85% and 40% respectively. The difference was substantial within that particular group. [13]
However, this was a cross-sectional study, meaning smoking and hair loss were assessed at one point rather than followed in an experiment. It shows an association, not proof that smoking alone caused the difference. It also cannot tell someone that stopping smoking will reverse established baldness. The finding is worth discussing without turning it into a guaranteed prediction about any one person’s hair.
Tight hairstyles and traction alopecia
Repeated pulling can damage hair, particularly where a hairstyle places most of its tension. Tight ponytails, braids, buns, extensions and weaves can contribute to traction alopecia. The affected area depends on where the pulling occurs, so it may show around the hairline, temples or between tightly styled sections. [14]
Early changes may improve when that tension stops. Continued pulling over a long period can permanently damage the follicles. If a style hurts, feels persistently tight or is accompanied by thinning, changing the style and seeking advice is sensible. Traction-related loss can coexist with other scalp conditions, so not every patch in a regularly styled area should be given the same explanation. [14]
The effect of hair loss on everyday life
The amount of visible hair loss does not necessarily tell you how much it matters to someone. A person with a small change may feel very self-conscious, while somebody with extensive loss may feel comfortable with it. Research helps describe those experiences, but it should not be used to tell people how they ought to feel.
In a European telephone survey published in 2005, 729 men aged 18–45 reported hair loss. Of these, 62% agreed that it could affect self-esteem and 43% were concerned about losing part of their personal attractiveness. The study included participants in the UK, alongside four other European countries. [12]
Confidence, appearance and emotional wellbeing
That survey found that 22% of the men reporting hair loss described a negative effect on social life. Its authors also noted limitations: hair loss was self-reported, and the tools used to measure psychological outcomes were not validated. The figures describe what those men said, not a diagnosis of depression or a measure of everyone’s experience. [12]
Separate UK primary-care research has examined the mental-health burden associated with alopecia areata, including depression and anxiety. [15] Emotional support is worth discussing if hair loss is affecting relationships, work or day-to-day confidence. There is no need to reach a particular degree of baldness before asking for that help, and choosing treatment is not the only way of responding to the change.
Work, social situations and other people’s opinions
Concerns about appearance can become especially noticeable before photographs, social events or an important meeting. The European survey explored men’s own perceptions of attractiveness and social life; it did not test whether employers reject applicants because they have less hair. Those are different claims and should not be presented as if one proves the other. [12]
Hair-loss treatment is a personal decision. A consultation should leave room to discuss what you want to change, what you are comfortable living with and whether treatment is worth the time and expense to you. No procedure can promise a better career, a relationship or a particular response from other people. The decision should rest on realistic changes to the hair itself.
What treatment statistics can actually tell you
Before comparing success rates, check what “success” means. A study might record extra hairs in a small measured area, a slower rate of thinning, a better photograph score or a patient saying they are satisfied. These outcomes are useful, but they are not equivalent. A treatment can slow further loss without restoring the density somebody remembers from their teens.
The length of follow-up matters too. A result measured after several months does not establish what will happen after ten years. Look for the treatment used, who took part, how improvement was measured and how many people completed the study. That information is more useful than a percentage presented without an explanation.
There is a similar trap with percentage increases. If a measured patch goes from 20 hairs to 30, that is a 50% increase, but it is still ten additional hairs in that patch. It does not mean that half a person's missing scalp hair has returned. This is an illustrative example, not a treatment result. In a clinical paper, the size of the measured area and the starting hair count are needed to understand what an increase could mean for visible coverage. Photographs taken under consistent conditions can help put the numbers into perspective.
Medicines and the importance of continued treatment
Minoxidil and finasteride are established treatments for male pattern hair loss, and topical minoxidil is also used for female pattern loss. They do not work for everybody, and their benefits generally depend on continuing treatment. A discussion about suitability therefore needs to include ongoing use, cost and possible side effects. [1]
Medicines used for pattern thinning should not automatically be applied to every other diagnosis. A person shedding after an illness may need a different approach from someone with alopecia areata or a scarring scalp condition. The diagnosis comes first; the choice of treatment follows from it. A product’s popularity is not evidence that it is appropriate for a particular scalp problem.
Minoxidil: what a controlled trial found
A 48-week trial published in 2002 enrolled 393 men aged 18–49 with androgenetic alopecia. It compared 5% topical minoxidil, 2% topical minoxidil and a placebo. The 5% treatment performed better than both comparison groups on hair counts and assessments of scalp coverage, with an earlier response than the 2% preparation. [16]
This is evidence of benefit in the men studied, not a guarantee that every user will regrow a full head of hair. The trial also recorded more itching and local irritation with the stronger solution. It studied topical solutions, so its findings should not be described as a comparison between foam and oral tablets. The preparation, instructions and suitability need to be checked for the person using it. [16]
Finasteride: benefits and limitations
Two trials published in 1998 included 1,553 men aged 18–41, comparing daily finasteride with placebo. A total of 1,215 continued into a second year. Researchers measured hair counts and reviewed photographs as well as patient and investigator assessments. Finasteride slowed the progression of loss and improved hair growth in the trial groups. [17]
That evidence should be considered alongside current safety information. The UK medicines regulator warns about depression, suicidal thoughts and sexual side effects, some of which may continue after treatment stops. Its advice is to stop finasteride 1 mg and contact a doctor promptly if depression or suicidal thoughts develop. A prescriber should discuss medical history and the patient information before treatment begins. [20]
Hair transplant facts and figures
A transplant moves existing follicles from a donor area into thinning or bald areas. It does not create an unlimited supply of new hair. The donor hair available, the area requiring coverage and the likely course of future loss all affect what can be achieved. These decisions need to be made before agreeing on a graft count. [21]
Results also take time. The NHS describes new growth commonly starting around four months after surgery, with full results expected over approximately 10–18 months. Transplanted hairs often shed first. Risks include infection, bleeding, visible scarring and grafts failing to grow, so a consultation should cover the possible limitations as well as the intended appearance. [18]
Who is having hair restoration surgery?
The ISHRS 2025 practice census reports on treatment carried out by its members in 2024. Respondents reported an average of 178 surgical procedures during the year. More than half of both male and female surgical patients were aged 30–49: 58.7% of men and 54.0% of women. [19]
These figures describe the practices that answered the survey. They do not establish what proportion of all UK adults have had a transplant, and they do not predict how many operations an individual will need. Someone having a procedure is also different from a procedure being counted: one person can undergo surgery more than once. That distinction matters when reading claims about the size of the industry.
FUE: individual graft removal
Follicular unit excision, commonly called FUE, removes individual follicular units using small punches. The grafts are then placed in the recipient area. It avoids the single linear donor scar associated with strip surgery, but it still leaves small scars where the units were removed. Describing it as scar-free would be misleading. [21]
The ISHRS census reported FUE as the most frequently used harvesting method among respondents in 2024. [19] Its popularity does not remove the need for careful planning. Taking too many grafts can leave the donor area visibly sparse, and extracting from areas likely to thin later can affect the durability of the result. The amount and distribution of suitable donor hair therefore matter more than simply aiming for the largest possible session. [21]
FUT: strip harvesting
Follicular unit transplantation, or FUT, usually refers to removing a narrow strip of hair-bearing scalp from the donor area. The strip is divided into individual follicular units for implantation, and the donor wound is closed. The main visible trade-off is a linear scar, which may be concealed by longer hair but can show with a short haircut. [22]
FUT remains an option in hair restoration and should not be dismissed as an obsolete procedure. Depending on the donor area and treatment plan, it can provide a substantial number of grafts without shaving the whole donor region. The choice between FUT and FUE should include scalp characteristics, previous surgery, preferred hairstyle and future graft needs. Neither technique can be declared the best for every patient. [22]
PRP: promising evidence, with limits
Platelet-rich plasma, or PRP, is prepared from a sample of the patient’s blood and injected into the scalp. A small randomised trial published in 2015 compared PRP with placebo on different areas of the same participants’ scalps. Twenty men completed the study after three of the 23 enrolled patients were excluded. Treatment was given in three sessions at roughly monthly intervals. [23]
The researchers reported improved hair density after treatment. However, a small study cannot establish a guaranteed result or the ideal schedule for everyone. A later meta-analysis comparing PRP with minoxidil found no clear advantage for PRP in several main outcomes and highlighted substantial differences between studies. [24] Ask what improvement is realistic, how it will be measured and what further sessions might involve before committing to a course.
A useful treatment plan should set out when the result will be reviewed and what would count as a worthwhile improvement. If other treatments are being used at the same time, ask how that will affect the assessment. It may be difficult to tell which part of a combined programme produced a change. Agreeing on photographs and review dates at the beginning makes it easier to judge progress without relying on memory or a different hairstyle.
Choosing the next step for your hair
Statistics can help you understand the options, but they cannot diagnose your scalp or choose a treatment for you. If the loss is sudden, patchy, painful or accompanied by skin changes, a medical assessment is a better starting point than buying a treatment package. Gradual thinning also deserves a clear explanation before you decide what to do about it.
At a consultation, ask what diagnosis fits your history, what each option could reasonably achieve and how progress will be checked. If surgery is being discussed, ask who will perform it, how the donor area will be assessed, what aftercare is included and what happens if there is a complication. You should leave with enough information to weigh up the benefits and limitations without feeling rushed into a decision. [18]
References
- NHS. Hair loss.
- British Association of Dermatologists. Male pattern hair loss.
- Birch MP and colleagues (2001). Hair density, hair diameter and the prevalence of female pattern hair loss.
- Rhodes T and colleagues (1998). Prevalence of male pattern hair loss in 18–49 year old men.
- Harries M and colleagues. The epidemiology of alopecia areata: a population-based cohort study in UK primary care.
- British Association of Dermatologists. Female pattern hair loss.
- British Association of Dermatologists. Alopecia areata.
- British Association of Dermatologists. Alopecia areata living guideline: clinical presentation and definitions.
- British Association of Dermatologists. Telogen effluvium.
- Etminan M and colleagues (2018). Risk of hair loss with different antidepressants: a comparative retrospective cohort study.
- US National Institutes of Health, Office of Dietary Supplements. Biotin: health professional fact sheet.
- Alfonso M and colleagues (2005). The psychosocial impact of hair loss among men: a multinational European study.
- Salem AS and colleagues (2021). Implications of cigarette smoking on early-onset androgenetic alopecia: a cross-sectional study.
- British Association of Dermatologists. Traction alopecia.
- Macbeth AE and colleagues (2022). The associated burden of mental health conditions in alopecia areata: a population-based study in UK primary care.
- Olsen EA and colleagues (2002). A randomised clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in men.
- Kaufman KD and colleagues (1998). Finasteride in the treatment of men with androgenetic alopecia.
- NHS. Hair transplant.
- International Society of Hair Restoration Surgery. 2025 practice census: procedures performed in 2024.
- MHRA (11 May 2026). Finasteride and dutasteride: updated safety warnings for psychiatric side effects and sexual dysfunction.
- International Society of Hair Restoration Surgery. FUE: benefits, procedure and risks.
- International Society of Hair Restoration Surgery. FUT: benefits, procedure and recovery.
- Gentile P and colleagues (2015). The effect of platelet-rich plasma in hair regrowth: a randomised placebo-controlled trial.
- Umar M and colleagues. Comparative efficacy and safety of platelet-rich plasma and minoxidil in androgenetic alopecia: systematic review and meta-analysis.




